Cosmetic cross-reference Noindex: medium evidence

496-72-0

CAS 496-72-0

496-72-0 (CAS 496-72-0) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
496-72-0
CAS Number
496-72-0
UNII
OE7HJ54P5C
InChIKey
DGRGLKZMKWPMOH-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1319452
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Potency 23041.941428571427 nM 69 -
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 496-72-0 used for in pharmaceutical contexts?

496-72-0 (CAS 496-72-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 496-72-0?

No adverse-event association or SIDER side-effect rows are rendered for 496-72-0 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 496-72-0 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Toluene-3,4-Diamine with EU status "prohibited".

What clinical phase is 496-72-0 in?

No phase 1-4 clinical development badge is rendered for 496-72-0 because the matched compound identifier rows do not contain a max-phase value.